Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Huizinga

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Journal of Innate Immunity|June 24, 2019
Men Have a Stronger Monocyte-Derived Cytokine Production Response upon Stimulation with the Gram-Negative Stimulus Lipopolysaccharide than Women: A Pooled Analysis Including 15 Study PopulationsKarel G M Beenakker, Rudi G J Westendorp, Anton J M de Craen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2020
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year resultsTineke Kraaij, Eline J Arends, Laura S van Dam, et al.
Journal of Crohn'S & Colitis|October 30, 2015
Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up StudyS J van Erp, L K Brakenhoff, F A van Gaalen, et al.
Arthritis Care & Research|June 28, 2012
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activityJeffrey R Curtis, Annette H van der Helm-van Mil, Rachel Knevel, et al.
Journal of Neuroimmunology|February 1, 1997
TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patientsT W Huizinga, R G Westendorp, E L Bollen, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohortsR Knevel, D P de Rooy, P K Gregersen, et al.
Journal of Autoimmunity|April 12, 2018
The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosusTineke Kraaij, Sylvia W A Kamerling, Esther N M de Rooij, et al.
Annals of the Rheumatic Diseases|February 19, 2014
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trialFrank Behrens, Paul P Tak, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trialNaomi B Klarenbeek, Sjoerd M van der Kooij, Tineke J W Huizinga, et al.
Nature Communications|May 6, 2015
Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritisJurgen van Heemst, Diahann T S L Jansen, Savvas Polydorides, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Journal of Innate Immunity|June 24, 2019
Men Have a Stronger Monocyte-Derived Cytokine Production Response upon Stimulation with the Gram-Negative Stimulus Lipopolysaccharide than Women: A Pooled Analysis Including 15 Study PopulationsKarel G M Beenakker, Rudi G J Westendorp, Anton J M de Craen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 28, 2020
Long-term effects of combined B-cell immunomodulation with rituximab and belimumab in severe, refractory systemic lupus erythematosus: 2-year resultsTineke Kraaij, Eline J Arends, Laura S van Dam, et al.
Journal of Crohn'S & Colitis|October 30, 2015
Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up StudyS J van Erp, L K Brakenhoff, F A van Gaalen, et al.
Arthritis Care & Research|June 28, 2012
Validation of a novel multibiomarker test to assess rheumatoid arthritis disease activityJeffrey R Curtis, Annette H van der Helm-van Mil, Rachel Knevel, et al.
Journal of Neuroimmunology|February 1, 1997
TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patientsT W Huizinga, R G Westendorp, E L Bollen, et al.
Annals of the Rheumatic Diseases|May 16, 2012
Studying associations between variants in TRAF1-C5 and TNFAIP3-OLIG3 and the progression of joint destruction in rheumatoid arthritis in multiple cohortsR Knevel, D P de Rooy, P K Gregersen, et al.
Journal of Autoimmunity|April 12, 2018
The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosusTineke Kraaij, Sylvia W A Kamerling, Esther N M de Rooij, et al.
Annals of the Rheumatic Diseases|February 19, 2014
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trialFrank Behrens, Paul P Tak, Mikkel Østergaard, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Blood pressure changes in patients with recent-onset rheumatoid arthritis treated with four different treatment strategies: a post hoc analysis from the BeSt trialNaomi B Klarenbeek, Sjoerd M van der Kooij, Tineke J W Huizinga, et al.
Nature Communications|May 6, 2015
Crossreactivity to vinculin and microbes provides a molecular basis for HLA-based protection against rheumatoid arthritisJurgen van Heemst, Diahann T S L Jansen, Savvas Polydorides, et al.
Pageof 16